Woman gets superbug with breast implant

June 16, 2012

Breast_Superbug

Mumbai, June 16: When a new mother from south Mumbai sought medical help for the significant distortion of her right breast, the term super-bug never crossed her mind. She may, however, be the most telling example of poor infection-control in Indian hospitals and the ensuing threat to patients undergoing surgeries.

The 30-year-old, who had undergone a breast implant surgery in 2009, was found to be suffering from an MRSA infection. MRSA (Methicillin-resistant Staphylococcus aureus) is one of the most potent superbugs or bacteria resistant to antibiotics. A few years back, the medical journal Lancet carried a series of controversial articles stating that newer superbugs such as NDM-1 (New Delhi Metallo-Beta-Lactamase 1) had emerged from India.

The young mother's right breast was not only more than double the size of the left, it was also lumpy and painful. An evaluation revealed that she first experienced firmness in her breast six months after the surgery, but she thought it was a result of her pregnancy. But the firmness worsened after she delivered her baby and started breast-feeding.

It was only when the doctors did an MRI scan did they realize that there was an infection in the lining (capsule) of the implant. "The MRI scan showed she was suffering from capsular contracture," said Dr Mohan Thomas, consultant cosmetic surgeon at Breach Candy Hospital. "She had undergone the cosmetic surgery in another hospital. By the time she came to us, the capsule (implant lining) of her right breast was about 12mm in size," he said, adding a normal lining does not go beyond 2mm in thickness.

The body reacts to any implant by forming a protective lining around it. This is referred to as the "capsule" or "tissue capsule" and is formed by one's own tissue. In some women, however, the capsule shrinks, squeezing the implant, referred to as capsular contracture. The tighter the capsule becomes, the firmer the breast feels.

It was only after her surgery that the reason for the capsular contracture was found. "While doing the surgery, a large amount of pus and fluid kept oozing out of her breast. We had to remove layers and layers of the capsule. After the surgery, we sent the fluid for examination and it turned out to be MRSA," said Dr Thomas. What surprised doctors was that clinical tests showed no signs of the infection, but only the fluid filled in the capsules showed the presence of the pathogens.

"If this pathogen had spread across the body, it could have killed the person. But in this woman's case, her capsule had taken the whole burden of this pathogen," said Dr Thomas. Worse, he said, she could have passed on the infection to her child since she was breast-feeding. After both her implants were removed, the doctors kept her in hospital until they were satisfied that she was free of infection.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 28,2020

New Delhi, May 28: BJP national spokesperson Sambit Patra has been admitted to a private hospital in Gurgaon after he showed symptoms of COVID-19, sources said.

He is admitted to the Medanta hospital in Gurgaon, hospital sources said on Thursday.

The BJP leader has shown symptoms of COVID-19, a source said.

Patra is one of the most visible BJP faces on news channels.

He is also very active on social media and posted several tweets on Thursday as well.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 30,2020

Kochi, Jul 30: The Kerala High Court on Thursday refused to grant the extension for the stay of a 74-year-old US citizen, Johnny Paul Pierce, who had earlier said that he felt safer to remain in India than in the United States amid the COVID-19 pandemic.

The single-judge bench of Justice CS Dias, which considered the writ petition, observed that the grant or extension of visa to foreign nationals fall exclusively within the domain of the Government of India (GoI) and that judicial review in such matters is minimal.

The power of the GoI to expel foreigners is absolute and unlimited, the bench said.

"In view of the categoric declaration of law by the Supreme Court, the plea of the petitioner to permit him to stay back in India cannot be accepted, as it falls within the purview of the guidelines and the discretion of the Government of India," the order said.

"The petitioner cannot be heard that the guidelines/policies/regulations formulated by the Government of India, that an American national though has been granted a visa having validity of five years has to leave India within 180 days, is irrational or unreasonable," it added.

The High Court, which was hearing a plea to permit the US citizen to stay in India for a further period of six months, said that the petitioner does not have a case that there is an infraction of Article 21 of the Constitution of India.

"The petitioner was well aware of the visa conditions when he arrived in India, and it is too late in the day for him to raise a grievance on the visa conditions," the bench said noting that the petitioner's love for India was heartening.

The High Court also directed the Foreigners Registration Officer to consider the petitioner's representation within a period of two weeks in accordance with the applicable guidelines and policies.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 26,2020

New Delhi, May 26: As India ranked 10th in the global infection list, overtaking Iran, which was an early hotspot of coronavirus, India's top medical body has said the human trials of COVID-19 vaccine may begin at least in six months.

Dr. Rajni Kant, Director Regional Medical Research Centre and Head at the Indian Council of Medical Research (ICMR) said, "The virus strain isolated at the National Institute of Virology (NIV) laboratory in Pune will be used to develop the vaccine, and this strain has been successfully transferred to the Bharat Biotech International Ltd. (BBIL). It is expected that the human trials of the vaccine will begin in at least six months."

Queried on the focus areas as India inches closer to 1.4 lakh COVID-19 cases, Kant said we should not get anxious about the rapid increase in numbers, especially in the past week, which saw 5,000 Covid-19 cases daily, instead focus on protecting the most vulnerable group.

"We should not fear from increasing Covid-19 cases. The elderly and people with comorbidities need protection. This is the highly vulnerable group, and we need to deploy resources and develop strategies to keep the mortality rate as low as possible in this group," said Kant.

Initially, it was assumed that the country would require thousands of ventilators, but last week, the health ministry said only 0.45 per cent of COVID-19 cases need ventilator support.

Kant insisted the focus should be on five per cent to 10 per cent serious patients. "We are testing more than one lakh daily and our case fatality rate is already one of the lowest in the world. In absence of vaccine, people should follow social distancing guidelines," he added

On the significance of the recovery rate, Kant said the increasing recovery rate of the COVID-19 patients, which is at 41 per cent, is a bright spot in India's fight against deadly viral infection.

Queried on large scale COVID-19 cases in Mumbai, Delhi and Ahmedabad, Kant said the population density in these regions is very high, which proves to be the just right environment for the viral infection.

He insisted on developing robust cluster management strategies in the hard-hit coronavirus spots, and the movement of people should be curtailed in these areas.

"Currently, a lot of people are moving around easily and avoiding social distancing norms. The first phase of the lockdown was very effective, but now things have changed," added Kant.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.